Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion

Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion

Abstract To evaluate outcomes of intravitreal bevacizumab (IVB) treating macular edema (ME) after retinal vein occlusion (RVO) following pro re nata (PRN) regimen and investigate potential predictors of non-response. Retrospective analysis of 126 treatment-naive eyes with ME after RVO. Eyes were tre...

Full description

Bibliographic Details
Main Authors: Wissam Aljundi, Florian Gradinger, Achim Langenbucher, Haris Sideroudi, Berthold Seitz, Alaa Din Abdin
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-27753-7

Internet

https://doi.org/10.1038/s41598-023-27753-7

Similar Items